Azathioprine has a very limited role in the treatment of Crohn's disease.
D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003424:Crohn Disease / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use; D011897:Random Allocation; D012460:Sulfasalazine / Q000627:therapeutic use
D012460:Sulfasalazine; D001379:Azathioprine; D011241:Prednisone